Pilot trial to evaluate the efficacy and tolerance of a simple once daily combined regimen including tenofovir (TDF), emtricitabine (FTC) and efavirenz (EFZ) [efavirenz/emtricitabine/tenofovir disoproxil fumarate] in HIV-1 infected patients naive to prior antiretroviral treatment in Senegal
Phase of Trial: Phase III
Latest Information Update: 02 Jul 2007
At a glance
- Drugs Efavirenz/emtricitabine/tenofovir-disoproxil-fumarate (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- 02 Jul 2007 Status changed from in progress to completed.
- 18 Nov 2005 New trial record.